Skip to main content

Table 3 Geometric mean ratios (week 96 to baseline) and 95% confidence intervals

From: Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

Biomarker (no. of samples per arm)

ABC/3TC + FPV/r

ABC/3TC + EFV

hs-CRP

0.99

1.59

 (n = 34, 32)

(0.56, 1.74)

(0.99, 2.56)

Plasminogen

0.73

0.61*

 (n = 34, 31)

(0.52, 1.02)

(0.44, 0.85)

sVCAM-1

0.52*

0.58*

 (n = 35, 32)

(0.46, 0.58)

(0.53, 0.64)

d-dimer

0.63*

0.61*

 (n = 35, 31)

(0.47, 0.84)

(0.48, 0.78)

Interleukin-6

0.77

0.89

 (n = 35, 32)

(0.53, 1.14)

(0.58, 1.36)

Fibrinogen

1.02

0.88*

 (n = 33, 30)

(0.93, 1.13)

(0.78, 0.99)

  1. * P < 0.05.